Tours, France

Aurélie Chantome

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Chu Nantes, National Institute of Health and Medical Research. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aurélie Chantome. Retrieved from https://idiyas.com/inventor/aurélie-chantome

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aurélie Chantome: Innovator in Cancer Treatment

Introduction

Aurélie Chantome is a notable inventor based in Tours, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds.

Latest Patents

Aurélie Chantome holds 1 patent for his invention titled "Ion channel inhibitor compounds for cancer treatment." This patent concerns a compound of the following general formula (I), which aims to provide new therapeutic options for cancer patients.

Career Highlights

Throughout his career, Aurélie has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Université d'Orléans. His work has focused on advancing scientific knowledge and developing practical applications for medical treatments.

Collaborations

Aurélie has collaborated with notable colleagues, including Sylvain Routier and Frédéric Buron. These partnerships have contributed to the success of his research and the development of innovative solutions in cancer treatment.

Conclusion

Aurélie Chantome's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His contributions continue to inspire future research and development in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…